Can ampicillin be used to treat urinary tract infections in children?

Can Ampicillin Be Used for UTI in Children?

Yes, ampicillin can be used for UTI in children, but its role is highly specific and age-dependent—it is primarily recommended for newborns and young infants (particularly those under 28 days old) in combination with an aminoglycoside, and should NOT be used as monotherapy for empiric treatment of UTI in older children due to high E. coli resistance rates. 1, 2

Age-Specific Recommendations

Newborns and Infants (8-28 days old)

• Ampicillin PLUS an aminoglycoside (gentamicin) is the recommended empiric regimen 2
  • Ampicillin: 150 mg/kg/day IV/IM divided every 8 hours
  • Gentamicin: 4 mg/kg/dose IV/IM every 24 hours
• This combination provides coverage for Group B Streptococcus, Enterococcus, and Listeria—pathogens more common in this age group 2
• Alternative: Ampicillin plus ceftazidime (150 mg/kg/day divided every 8 hours) 1

Infants with Pyelonephritis (<6 months)

• Ceftazidime plus ampicillin, OR aminoglycoside plus ampicillin 1
• For complicated pyelonephritis at any age, the same combination applies 1

Children >6 months and 2-24 months

• Ampicillin is NOT recommended as first-line empiric therapy 1, 3
• Preferred agents: Amoxicillin-clavulanate, sulfamethoxazole-trimethoprim, or cephalosporins 1, 3
• For children >28 days requiring parenteral therapy: Ceftriaxone 50 mg/kg/dose IV/IM every 24 hours 2

Critical Resistance Considerations

The WHO Expert Committee explicitly removed amoxicillin (and by extension, ampicillin monotherapy) from recommended options for lower UTI in 2021 due to alarming resistance data: 1

• Global surveillance showed a median of 75% (range 45-100%) of E. coli urinary isolates resistant to amoxicillin 1
• E. coli is the most common pediatric UTI pathogen
• Ampicillin monotherapy carries unacceptable risk of treatment failure in older infants and children

When Ampicillin Works Despite Resistance

Interestingly, for lower urinary tract infections only, ampicillin may achieve clinical cure even with resistant organisms due to extremely high urinary concentrations 4, 5. However, this principle:

• Does NOT apply to febrile UTI/pyelonephritis where systemic/parenchymal concentrations matter 3
• Should NOT guide empiric therapy decisions in children
• Is primarily studied in adults with VRE

Practical Algorithm

For empiric treatment of pediatric UTI:

1. Age 8-21 days with UTI: Ampicillin + gentamicin (or ceftazidime) 2

2. Age 22-28 days with UTI: Ceftriaxone monotherapy (ampicillin combinations acceptable but not preferred) 2

3. Age >28 days with UTI:

   • Oral therapy if well-appearing: Amoxicillin-clavulanate, cephalexin, or cefixime 2, 3
   • Parenteral therapy if toxic-appearing: Ceftriaxone 2
   • Do NOT use ampicillin monotherapy 1

4. Adjust based on culture results: If organism is ampicillin-susceptible, may narrow to ampicillin for cost/spectrum considerations 6

Common Pitfalls

• Never use ampicillin monotherapy empirically in children >1 month old for UTI—resistance rates are prohibitive 1
• Do not use nitrofurantoin for febrile UTI/pyelonephritis in any age—inadequate tissue concentrations despite urinary efficacy 3
• Always combine ampicillin with aminoglycoside in neonates—monotherapy misses critical pathogens 2
• Ampicillin-sulbactam showed efficacy in one small study 7, but lacks guideline support and is not standard practice

Duration of Therapy

When ampicillin is used (in appropriate combinations for young infants): 7-14 days total 3